Nutrien (NYSE:NTR) Given New $65.00 Price Target at UBS Group

Nutrien (NYSE:NTRGet Free Report) had its price objective reduced by investment analysts at UBS Group from $67.00 to $65.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “sell” rating on the stock. UBS Group’s price objective would suggest a potential downside of 8.88% from the stock’s current price.

A number of other equities analysts have also recently commented on NTR. Wall Street Zen raised Nutrien from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Mizuho upped their price target on Nutrien from $65.00 to $68.00 and gave the stock a “neutral” rating in a research report on Friday, January 16th. BNP Paribas Exane downgraded Nutrien from an “outperform” rating to a “neutral” rating in a research note on Monday, February 23rd. Bank of America raised Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective on the stock in a research report on Thursday, April 30th. Finally, Wells Fargo & Company upgraded Nutrien from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $77.00 to $100.00 in a research note on Friday, March 13th. Eleven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $82.63.

Get Our Latest Research Report on Nutrien

Nutrien Stock Performance

NYSE NTR traded up $3.01 during trading hours on Monday, hitting $71.34. 3,715,715 shares of the company’s stock traded hands, compared to its average volume of 3,531,165. Nutrien has a 52 week low of $53.03 and a 52 week high of $85.36. The firm has a market capitalization of $34.30 billion, a P/E ratio of 14.53 and a beta of 0.64. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35. The business’s fifty day moving average price is $74.93 and its two-hundred day moving average price is $66.96.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.03. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.30 billion. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The company’s quarterly revenue was up 18.5% on a year-over-year basis. During the same period last year, the firm earned $0.11 earnings per share. Equities research analysts predict that Nutrien will post 5.09 EPS for the current year.

Institutional Trading of Nutrien

Several hedge funds have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Nutrien by 65.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company’s stock worth $1,253,000 after buying an additional 9,950 shares in the last quarter. NewEdge Advisors LLC grew its holdings in Nutrien by 6.2% during the 1st quarter. NewEdge Advisors LLC now owns 6,907 shares of the company’s stock valued at $343,000 after buying an additional 404 shares in the last quarter. Focus Partners Wealth purchased a new position in Nutrien during the 1st quarter valued at approximately $516,000. Acadian Asset Management LLC bought a new stake in Nutrien in the 1st quarter worth approximately $54,000. Finally, Prudential Financial Inc. bought a new stake in Nutrien in the 2nd quarter worth approximately $203,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

About Nutrien

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Read More

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.